Fractyl Health

Fractyl Health is an organ editing metabolic therapeutics company focused on pioneering a new approach to the treatment of Type 2 Diabetes (T2D). Our goal is to transform T2D treatment from chronic blood glucose management to disease-modifying therapies that target the organ-level root causes of metabolic disease. We have assembled a mission-driven team full of innovators, united in a passion to eradicate type 2 diabetes and to develop breakthrough therapies—the type of therapies we would want for our family members and loved ones with the disease. Through our accomplished board of directors, investors, and scientific advisors, we have access to some of the most insightful minds in the global scientific and biopharma landscape.